Skip to content

PERSOMED

Dissolved and wound up KBO/BCE: BE 0759.439.130

Timeline

7 events since 2020
2024
Dissolution with immediate closure of the liquidationDissolved and wound up in a single deed · Books and records kept in Gent Ottergemsesteenweg (5 years) · Resignations: QbD Flanders, ANTLERON, MyNeo and IMMUNO-CONSULT · General meeting of 28-03-202413 points ▸
  • General meeting, 28-03-2024
  • Director resignation, QbD Flanders
  • Director resignation, ANTLERON
  • Director resignation, MyNeo
  • Director resignation, IMMUNO-CONSULT
  • Permanent representative, VAN ACKER Bart
  • Permanent representative, SCHROOTEN Jan
  • Permanent representative, BOGAERT Cedric
  • Permanent representative, THIELEMANS Kristiaan
  • Power of attorney, QbD Flanders
  • Power of attorney, ANTLERON
  • Power of attorney, MyNeo
  • Power of attorney, IMMUNO-CONSULT
  • The deed holds 5 more points.

Open the deed in the Belgian Official Gazette

Annual accounts 2023 filed PDFmicro format · 118 days before the deadline
2023
Annual accounts 2022 filed PDFmicro format · 24 days before the deadline
Capital increase of €41,500.012,074,999 new shares · Changes of role: QbD Flanders, ANTLERON, MyNeo and IMMUNO-CONSULT · Permanent representatives: VAN ACKER Bart, SCHROOTEN Jan, BOGAERT Cedric and THIELEMANS Kristiaan · General meeting of 31-03-202317 points ▸
  • General meeting, 31-03-2023
  • Legal-form conversion, to private limited company
  • Director resignation, QbD Flanders (manager)
  • Permanent representative, VAN ACKER Bart, mentioned twice in the deed
  • Director resignation, ANTLERON (manager)
  • Permanent representative, SCHROOTEN Jan, mentioned twice in the deed
  • Director resignation, MyNeo (manager)
  • Permanent representative, BOGAERT Cedric, mentioned twice in the deed
  • Director resignation, IMMUNO-CONSULT (manager)
  • Permanent representative, THIELEMANS Kristiaan, mentioned twice in the deed
  • Capital increase, €41,500.01
  • Board rule, 4
  • Director appointment, QbD Flanders (director (not named in the articles))
  • Director appointment, ANTLERON (director (not named in the articles))
  • Director appointment, MyNeo (director (not named in the articles))
  • Director appointment, IMMUNO-CONSULT (director (not named in the articles))
  • Director appointment, BOGAERT Cedric (director (executive))
  • The deed holds 12 more points.

Open the deed in the Belgian Official Gazette

Permanent representatives: Cedric Bogaert, Van Acker Bart, Schrooten Jan, Thielemans Kris and Jan Van den Berghe5 points ▸
  • Permanent representative, Cedric Bogaert
  • Permanent representative, Van Acker Bart
  • Permanent representative, Schrooten Jan
  • Permanent representative, Thielemans Kris
  • Permanent representative, Jan Van den Berghe

Open the deed in the Belgian Official Gazette

2022
Registered office moved within WilrijkNew registered office: Groenenborgerlaan 16, 2610 Wilrijk · Previous registered office: Fotografielaan 5, 2610 Wilrijk · General meeting of 01-09-20222 points ▸
  • General meeting, 01-09-2022
  • Registered-office move, Groenenborgerlaan 16, 2610 Wilrijk
  • The deed holds 1 more point.

Open the deed in the Belgian Official Gazette

2020
IncorporationFounding capital of €20,000, 1,000 shares · Founders: Quality By Design NV, Antleron NV, MyNeo NV and 2 others · Appointments: Quality By Design NV, Antleron NV, MyNeo NV and Immuno-Consult BV15 points ▸

Open the deed in the Belgian Official Gazette

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

The deed of incorporation of PERSOMED was published in the Belgian Official Gazette on 8 December 2020.1 The registered office was moved to Wilrijk in 2022.2 In 2023 the capital was increased by €41,500.3 In 2024 the company was dissolved and its liquidation closed in a single deed.4

  1. 1Belgian Official Gazette, 08-12-2020
  2. 2Belgian Official Gazette, 10-11-2022
  3. 3Belgian Official Gazette, 11-04-2023
  4. 4Belgian Official Gazette, 21-05-2024